MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yanagita, T.
Right arrow Articles by Wada, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yanagita, T.
Right arrow Articles by Wada, A.

Vol. 63, Issue 5, 1125-1136, May 2003

Destabilization of Nav1.7 Sodium Channel alpha -Subunit mRNA by Constitutive Phosphorylation of Extracellular Signal-Regulated Kinase: Negative Regulation of Steady-State Level of Cell Surface Functional Sodium Channels in Adrenal Chromaffin Cells

Toshihiko Yanagita, Hideyuki Kobayashi, Yasuhito Uezono, Hiroki Yokoo, Takashi Sugano, Tomokazu Saitoh, Shin-Ichi Minami, Seiji Shiraishi, and Akihiko Wada

Department of Pharmacology, Miyazaki Medical College, Miyazaki, Japan

In cultured bovine adrenal chromaffin cells expressing Nav1.7 isoform of voltage-dependent Na+ channels, treatment (>= 6 h) with serum deprivation, PD98059, or U0126 increased cell surface [3H]saxitoxin ([3H]STX) binding by ~58% (t1/2 = 12.5 h), with no change in the Kd value. Immunoblot analysis showed that either treatment attenuated constitutive phosphorylation of extracellular signal-regulated kinase (ERK) 1 and ERK2 but not of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase (JNK) 1 and JNK2. The increase of [3H]STX binding and the attenuated phosphorylation of ERK1 and ERK2 returned to the control nontreated levels after the addition of serum or the washout of PD98059- or U0126-treated cells. Simultaneous treatment of serum deprivation with PD98059 or U0126 did not produce an additional increasing effect on [3H]STX binding, compared with either treatment alone. In cells subjected to either treatment, veratridine-induced maximum 22Na+ influx was augmented by ~47%, with no change in the EC50 value; Ptychodiscus brevis toxin-3 enhanced veratridine-induced 22Na+ influx by 2-fold, as in nontreated cells. Serum deprivation, PD98059, or U0126 increased Na+ channel alpha - but not beta 1- subunit mRNA level by ~50% between 3 and 24 h; cycloheximide, an inhibitor of protein synthesis, increased alpha -subunit mRNA level and nullified additional increasing effect of either treatment on alpha -subunit mRNA level. Either treatment prolonged half-life of alpha -subunit mRNA from 17.5 to ~26.3 h without altering alpha -subunit gene transcription. Thus, constitutively phosphorylated/activated ERK destabilizes Na+ channel alpha -subunit mRNA via translational event, which negatively regulates steady-state level of alpha -subunit mRNA and cell surface expression of functional Na+ channels.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. K. Wittmack, A. M. Rush, A. Hudmon, S. G. Waxman, and S. D. Dib-Hajj
Voltage-Gated Sodium Channel Nav1.6 Is Modulated by p38 Mitogen-Activated Protein Kinase
J. Neurosci., July 13, 2005; 25(28): 6621 - 6630.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. De Luca, B. Nico, A. Liantonio, M. P. Didonna, B. Fraysse, S. Pierno, R. Burdi, D. Mangieri, J.-F. Rolland, C. Camerino, et al.
A Multidisciplinary Evaluation of the Effectiveness of Cyclosporine A in Dystrophic Mdx Mice
Am. J. Pathol., February 1, 2005; 166(2): 477 - 489.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics